ResMed announced at the ESC Congress 2013 that SERVE-HF has completed enrollment.1 SERVE-HF is an international, randomised study of 1,325 participants investigating if the treatment of central sleep-disordered breathing (central sleep apnea) improves survival and outcomes of patients with stable heart failure.

Edwards announced a new post-hoc data analysis from The PARTNER Trial demonstrated that diabetic patients with aortic stenosis in need of heart valve replacement, but at high surgical risk, experienced a 35 percent lower relative all-cause mortality one year after treatment with transcatheter aortic valve replacement (TAVR), as compared to those treated with surgical aortic valve replacement (AVR).

Toshiba’s Vantage Titan 3.0T offers true comfort and flexibility with the power of 3.0T. The system is very quiet and features a large bore to put patients at ease. It also overcomes the clinical limitations of traditional 3.0T with advanced multi-port RF transmission technology, providing more uniformity and coverage to produce better body images.

 

In an independent study presented during the North American Spine Society (NASS) Annual Meeting in October 2012, GE Healthcare’s OEC Elite 9900 mobile C-arm was rated the best in image quality and dose management.

Aggredyne Inc., has received ISO 13485 certification for its quality control program related to the manufacture of the AggreGuide family of platelet function analyzers.


Cardiologists are increasingly accessing coronary arteries by way of the wrist rather than the groin to insert life-saving stents into patients with blocked arteries, according to the first broad report of the American College of Cardiology’s clinical data registries published online in the Journal of the American College of Cardiology.

OrbusNeich Medical Inc. and Boston Scientific Corp. have settled all stent-related litigation between the companies.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now